CRISPR/Cas9 can be deployed for modification of biosynthetic pathways for directing the intermediate products into the harmless or comparatively less harmful or beneficial compound, either by ...

Industrial fermentation using bacteria, yeast and other microbes to produce specific products has the potential to reduce ...

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran 1449614535, Iran Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University ...

† Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Shirokanedai 4-6-1, Minato-ku, Tokyo 108-8639, Japan ‡ Department of General ...

What were the key drivers for BBL’s growth in the fourth quarter of FY25? Achieving 15 per cent year-on-year revenue growth, with nearly four biosimilars generating $200 million in revenue, is a huge ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

a personalized treatment to fix the baby's genome using what amounts to a pair of molecular scissors – the technique called Crispr-Cas9, which earned its creators the Nobel prize for chemistry in 2020 ...

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the age and credit for inventing it. The CRISPR patents are back in play.

The applications did not adequately show possession of an operable CRISPR-Cas9 system in eukaryotic cells, even though they described the core components of the technology. As a result ...

Sanjay Basu, Waymark, San Francisco, California. Kasia J. Lipska, Yale University. Insulin is considered an essential medicine for people with diabetes, but its price has doubled during the past ...